The medicinal potential of influenza virus surface proteins: Hemagglutinin and neuraminidase

Current Medicinal Chemistry

Volumn 18, Issue 7, 2011, Pages 1050-1066

  Xie, Y ^a   Gong, J ^a   Li, M ^a   Fang, H ^a   Xu, W ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Antibody; Antigenic shift; Hemagglutinin; Influenza; Inhibitor; Membrane fusion; Neuraminidase; Receptor specificity

Indexed keywords

5,7,4' TRIHYDROXY 8 METHOXYFLAVONE; A 315675; ABT 675; ANTIVIRUS AGENT; ARBIDOL; AURINTRICARBOXYLIC ACID; CATECHIN; CURCUMIN; DAS 181; ENFUVIRTIDE; EPITOPE; FLAVANONE DERIVATIVE; FLAVONOID; FLAVONOL DERIVATIVE; HEMAGGLUTININ INHIBITOR; INFLUENZA VIRUS HEMAGGLUTININ; ISOFLAVONE DERIVATIVE; LANINAMIVIR OCTANOATE; MARAVIROC; OSELTAMIVIR; PERAMIVIR; PROTEIN ANTIBODY; PTEROCARPAN DERIVATIVE; RIBAVIRIN; SIALIDASE INHIBITOR; TERT BUTYL HYDROQUINONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS SIALIDASE; XANTHONE DERIVATIVE; ZANAMIVIR;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG STRUCTURE; IC 50; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H2N2; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N2; INFLUENZA VIRUS B; INFLUENZA VIRUS C; LIFE CYCLE; NONHUMAN; PHYLOGENY; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN STRUCTURE; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RECEPTOR BINDING; VIRUS INHIBITION;

ANTIVIRAL AGENTS; ENZYME INHIBITORS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; NEURAMINIDASE;

EID: 79952801722     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986711794940815     Document Type: Article

References (185)

1. Tumpey, T.M.; Belser, J.A. Resurrected pandemic influenza viruses. Annu. Rev. Microbiol., 2009, 63, 79-98.
2. Neumann, G.; Noda, T.; Kawaoka, Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature, 2009, 459(7249), 931-939.
3. Mossong, J.; Opp, M.; Gerloff, N.; Hau, P.; Kremer, J.; Lackenby, A.; Gregory, V.; Even, J.; Huberty-Krau, P.; Muller, C.P.; Schneider, F. Emergence of oseltamivir-resistant influenza A H1N1 virus during the 2007- 2008 winter season in Luxembourg: Clinical characteristics and epidemiology. Antiviral Res., 2009, 84(1), 91-94.
4. Krug, R.M.; Aramini, J.M. Emerging antiviral targets for influenza A virus. Trends Pharmacol. Sci., 2009, 30(6), 269-277.
5. Lee, C.W.; Saif, Y.M. Avian influenza virus. Comp. Immunol. Microbiol. Infect. Dis., 2009, 32(4), 301-310.
6. Steinhauer, D.A.; Skehel, J.J. Genetics of influenza viruses. Annu. Rev. Genet., 2002, 36, 305-332. (Pubitemid 36109192)
7. Skehel, J.J.; Wiley, D.C. Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin. Annu. Rev. Biochem., 2000, 69, 531-569.
8. Russell, R.J.; Gamblin, S.J.; Haire, L.F.; Stevens, D.J.; Xiao, B.; Ha, Y.; Skehel, J.J. H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes. Virology, 2004, 325(2), 287-296. (Pubitemid 38902794)
9. Fouchier, R.A.; Munster, V.; Wallensten, A.; Bestebroer, T.M.; Herfst, S.; Smith, D.; Rimmelzwaan, G.F.; Olsen, B.; Osterhaus, A.D. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J. Virol., 2005, 79(5), 2814-2822. (Pubitemid 40270559)
10. Wilson, I.A.; Skehel, J.J.; Wiley, D.C. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature, 1981, 289(5796), 366-373.
11. Lin, T.; Wang, G.; Li, A.; Zhang, Q.; Wu, C.; Zhang, R.; Cai, Q.; Song, W.; Yuen, K.Y. The hemagglutinin structure of an avian H1N1 influenza A virus. Virology, 2009, 392(1), 73-81.
12. Stevens, J.; Blixt, O.; Tumpey, T.M.; Taubenberger, J.K.; Paulson, J.C.; Wilson, I.A. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science, 2006, 312(5772), 404-410.
13. Ha, Y.; Stevens, D.J.; Skehel, J.J.; Wiley, D.C. X-ray structures of H5 avian and H9 swine influenza virus hemagglutinins bound to avian and human receptor analogs. Proc. Natl. Acad. Sci. U. S. A., 2001, 98(20), 11181-11186. (Pubitemid 32928703)
14. Kuiken, T.; Holmes, E.C.; McCauley, J.; Rimmelzwaan, G.F.; Williams, C.S.; Grenfell, B.T. Host species barriers to influenza virus infections. Science, 2006, 312(5772), 394-397.
15. Chen, J.; Lee, K.H.; Steinhauer, D.A.; Stevens, D.J.; Skehel, J.J.; Wiley, D.C. Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell, 1998, 95(3), 409-417. (Pubitemid 28507328)
16. Stech, O.; Veits, J.; Weber, S.; Deckers, D.; Schroer, D.; Vahlenkamp, T.W.; Breithaupt, A.; Teifke, J.; Mettenleiter, T.C.; Stech, J. Acquisition of a polybasic hemagglutinin cleavage site by a low-pathogenic avian influenza virus is not sufficient for immediate transformation into a highly pathogenic strain. J. Virol., 2009, 83(11), 5864-5868.
17. Harrison, S.C. Viral membrane fusion. Nat. Struct. Mol. Biol., 2008, 15(7), 690-698. (Pubitemid 351932011)
18. Cross, K.J.; Langley, W.A.; Russell, R.J.; Skehel, J.J.; Steinhauer, D.A. Composition and functions of the influenza fusion peptide. Protein Pept. Lett., 2009, 16(7), 766-778.
19. Carr, C.M.; Chaudhry, C.; Kim, P.S. Influenza hemagglutinin is springloaded by a metastable native conformation. Proc. Natl. Acad. Sci. U. S. A., 1997, 94(26), 14306-14313. (Pubitemid 28041369)
20. Carr, C.M.; Kim, P.S. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell, 1993, 73(4), 823-832. (Pubitemid 23159019)
21. Swalley, S.E.; Baker, B.M.; Calder, L.J.; Harrison, S.C.; Skehel, J.J.; Wiley, D.C. Full-length influenza hemagglutinin HA2 refolds into the trimeric lowpH- induced conformation. Biochemistry, 2004, 43(19), 5902-5911. (Pubitemid 38623623)
22. Rachakonda, P.S.; Veit, M.; Korte, T.; Ludwig, K.; Bottcher, C.; Huang, Q.; Schmidt, M.F.; Herrmann, A. The relevance of salt bridges for the stability of the influenza virus hemagglutinin. FASEB J., 2007, 21(4), 995-1002. (Pubitemid 46495718)
23. Huang, Q.; Opitz, R.; Knapp, E.W.; Herrmann, A. Protonation and stability of the globular domain of influenza virus hemagglutinin. Biophys. J., 2002, 82(2), 1050-1058. (Pubitemid 34111241)
24. Huang, Q.; Sivaramakrishna, R.P.; Ludwig, K.; Korte, T.; Bottcher, C.; Herrmann, A. Early steps of the conformational change of influenza virus hemagglutinin to a fusion active state: Stability and energetics of the hemagglutinin. Biochim. Biophys. Acta, 2003, 1614(1), 3-13. (Pubitemid 36851599)
25. Thoennes, S.; Li, Z.N.; Lee, B.J.; Langley, W.A.; Skehel, J.J.; Russell, R.J.; Steinhauer, D.A. Analysis of residues near the fusion peptide in the influenza hemagglutinin structure for roles in triggering membrane fusion. Virology, 2008, 370(2), 403-414. (Pubitemid 350199676)
26. Reed, M.L.; Yen, H.L.; DuBois, R.M.; Bridges, O.A.; Salomon, R.; Webster, R.G.; Russell, C.J. Amino acid residues in the fusion peptide pocket regulate the pH of activation of the H5N1 influenza virus hemagglutinin protein. J. Virol., 2009, 83(8), 3568-3580.
27. Casali, M.; Banta, S.; Zambonelli, C.; Megeed, Z.; Yarmush, M.L. Sitedirected mutagenesis of the hinge peptide from the hemagglutinin protein: Enhancement of the pH-responsive conformational change. Protein Eng. Des. Sel., 2008, 21(6), 395-404. (Pubitemid 351786658)
28. Huang, Q.; Korte, T.; Rachakonda, P.S.; Knapp, E.W.; Herrmann, A. Energetics of the loop-to-helix transition leading to the coiled-coil structure of influenza virus hemagglutinin HA2 subunits. Proteins, 2009, 74(2), 291-303.
29. Leikina, E.; Ramos, C.; Markovic, I.; Zimmerberg, J.; Chernomordik, L.V. Reversible stages of the low-pH-triggered conformational change in influenza virus hemagglutinin. EMBO J., 2002, 21(21), 5701-5710. (Pubitemid 35315270)
30. Bentz, J. Membrane fusion mediated by coiled coils: A hypothesis. Biophys. J., 2000, 78(2), 886-900. (Pubitemid 30211846)
31. Cheng, S.F.; Kantchev, A.B.; Chang, D.K. Fluorescence evidence for a loose self-assembly of the fusion peptide of influenza virus HA2 in the lipid bilayer. Mol. Membr. Biol., 2003, 20(4), 345-351. (Pubitemid 37392090)
32. Han, X.; Tamm, L.K. pH-dependent self-association of influenza hemagglutinin fusion peptides in lipid bilayers. J. Mol. Biol., 2000, 304(5), 953-965. (Pubitemid 32047093)
33. Danieli, T.; Pelletier, S.L.; Henis, Y.I.; White, J.M. Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers. J. Cell. Biol., 1996, 133(3), 559-569. (Pubitemid 26160968)
34. Imai, M.; Mizuno, T.; Kawasaki, K. Membrane fusion by single influenza hemagglutinin trimers. Kinetic evidence from image analysis of hemagglutinin-reconstituted vesicles. J. Biol. Chem., 2006, 281(18), 12729-12735. (Pubitemid 43855363)
35. Chang, D.K.; Cheng, S.F. pH-dependence of intermediate steps of membrane fusion induced by the influenza fusion peptide. Biochem. J., 2006, 396(3), 557-563.
36. Tatulian, S.A.; Hinterdorfer, P.; Baber, G.; Tamm, L.K. Influenza hemagglutinin assumes a tilted conformation during membrane fusion as determined by attenuated total reflection FTIR spectroscopy. EMBO J., 1995, 14(22), 5514-5523.
37. Lai, A.L.; Park, H.; White, J.M.; Tamm, L.K. Fusion peptide of influenza hemagglutinin requires a fixed angle boomerang structure for activity. J. Biol. Chem., 2006, 281(9), 5760-5770. (Pubitemid 43847675)
38. Lai, A.L.; Tamm, L.K. Locking the kink in the influenza hemagglutinin fusion domain structure. J. Biol. Chem., 2007, 282(33), 23946-23956. (Pubitemid 47328033)
39. Han, X.; Bushweller, J.H.; Cafiso, D.S.; Tamm, L.K. Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin. Nat. Struct. Biol., 2001, 8(8), 715-720. (Pubitemid 32757933)
40. Jang, H.; Michaud-Agrawal, N.; Johnston, J.M.; Woolf, T.B. How to lose a kink and gain a helix: PH independent conformational changes of the fusion domains from influenza hemagglutinin in heterogeneous lipid bilayers. Proteins, 2008, 72(1), 299-312. (Pubitemid 351809168)
41. Ge, M.; Freed, J.H. Fusion peptide from influenza hemagglutinin increases membrane surface order: An electron-spin resonance study. Biophys. J., 2009, 96(12), 4925-4934.
42. Chernomordik, L.V.; Kozlov, M.M. Mechanics of membrane fusion. Nat. Struct. Mol. Biol., 2008, 15(7), 675-683. (Pubitemid 351932010)
43. Gruenke, J.A.; Armstrong, R.T.; Newcomb, W.W.; Brown, J.C.; White, J.M. New insights into the spring-loaded conformational change of influenza virus hemagglutinin. J. Virol., 2002, 76(9), 4456-4466. (Pubitemid 34309582)
44. Fuhrmans, M.; Knecht, V.; Marrink, S.J. A single bicontinuous cubic phase induced by fusion peptides. J. Am. Chem. Soc., 2009, 131(26), 9166-9167.
45. Schaub, J.R.; Lu, X.; Doneske, B.; Shin, Y.K.; McNew, J.A. Hemifusion arrest by complexin is relieved by Ca2+-synaptotagmin I. Nat. Struct. Mol. Biol., 2006, 13(8), 748-750. (Pubitemid 44175169)
46. Borrego-Diaz, E.; Peeples, M.E.; Markosyan, R.M.; Melikyan, G.B.; Cohen, F.S. Completion of trimeric hairpin formation of influenza virus hemagglutinin promotes fusion pore opening and enlargement. Virology, 2003, 316(2), 234-244. (Pubitemid 37468527)
47. Reese, C.; Mayer, A. Transition from hemifusion to pore opening is rate limiting for vacuole membrane fusion. J. Cell. Biol., 2005, 171(6), 981-990. (Pubitemid 41815830)
48. Floyd, D.L.; Ragains, J.R.; Skehel, J.J.; Harrison, S.C.; van Oijen, A.M. Single-particle kinetics of influenza virus membrane fusion. Proc. Natl. Acad. Sci. U. S. A., 2008, 105(40), 15382-15387.
49. Park, H.E.; Gruenke, J.A.; White, J.M. Leash in the groove mechanism of membrane fusion. Nat. Struct. Biol., 2003, 10(12), 1048-1053. (Pubitemid 37500497)
50. Chang, D.K.; Cheng, S.F.; Kantchev, E.A.; Lin, C.H.; Liu, Y.T. Membrane interaction and structure of the transmembrane domain of influenza hemagglutinin and its fusion peptide complex. BMC Biol., 2008, 6, 2.
51. Biswas, S.; Yin, S.R.; Blank, P.S.; Zimmerberg, J. Cholesterol promotes hemifusion and pore widening in membrane fusion induced by influenza hemagglutinin. J. Gen. Physiol., 2008, 131(5), 503-513. (Pubitemid 351620106)
52. Varki, A. Glycan-based interactions involving vertebrate sialic-acidrecognizing proteins. Nature., 2007, 446(7139), 1023-1029. (Pubitemid 46676064)
53. Matrosovich, M.N.; Matrosovich, T.Y.; Gray, T.; Roberts, N.A.; Klenk, H.D. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc. Natl. Acad. Sci. U. S. A., 2004, 101(13), 4620-4624. (Pubitemid 38437460)
54. Shinya, K.; Ebina, M.; Yamada, S.; Ono, M.; Kasai, N.; Kawaoka, Y. Avian flu: Influenza virus receptors in the human airway. Nature, 2006, 440(7083), 435-436.
55. Matrosovich, M.; Tuzikov, A.; Bovin, N.; Gambaryan, A.; Klimov, A.; Castrucci, M.R.; Donatelli, I.; Kawaoka, Y. Early alterations of the receptorbinding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J. Virol., 2000, 74(18), 8502-8512. (Pubitemid 30666701)
56. Kilbourne, E.D. Influenza pandemics of the 20th century. Emerg. Infect. Dis., 2006, 12(1), 9-14. (Pubitemid 43143528)
57. Tumpey, T.M.; Basler, C.F.; Aguilar, P.V.; Zeng, H.; Solorzano, A.; Swayne, D.E.; Cox, N.J.; Katz, J.M.; Taubenberger, J.K.; Palese, P.; Garcia-Sastre, A. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science, 2005, 310(5745), 77-80. (Pubitemid 41434537)
58. Oyelaran, O.; Gildersleeve, J.C. Glycan arrays: Recent advances and future challenges. Curr. Opin. Chem. Biol., 2009, 13(4), 406-413.
59. Taylor, M.E.; Drickamer, K. Structural insights into what glycan arrays tell us about how glycan-binding proteins interact with their ligands. Glycobiology, 2009, 19(11), 1155-1162.
60. Basler, C.F.; Reid, A.H.; Dybing, J.K.; Janczewski, T.A.; Fanning, T.G.; Zheng, H.; Salvatore, M.; Perdue, M.L.; Swayne, D.E.; Garcia-Sastre, A.; Palese, P.; Taubenberger, J.K. Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes. Proc. Natl. Acad. Sci. U. S. A., 2001, 98(5), 2746-2751. (Pubitemid 32209554)
61. Stevens, J.; Corper, A.L.; Basler, C.F.; Taubenberger, J.K.; Palese, P.; Wilson, I.A. Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science, 2004, 303(5665), 1866-1870. (Pubitemid 38374878)
62. Gamblin, S.J.; Haire, L.F.; Russell, R.J.; Stevens, D.J.; Xiao, B.; Ha, Y.; Vasisht, N.; Steinhauer, D.A.; Daniels, R.S.; Elliot, A.; Wiley, D.C.; Skehel, J.J. The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science, 2004, 303(5665), 1838-1842. (Pubitemid 38374870)
63. Stevens, J.; Blixt, O.; Glaser, L.; Taubenberger, J.K.; Palese, P.; Paulson, J.C.; Wilson, I.A. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J. Mol. Biol., 2006, 355(5), 1143-1155. (Pubitemid 43012153)
64. Glaser, L.; Stevens, J.; Zamarin, D.; Wilson, I.A.; Garcia-Sastre, A.; Tumpey, T.M.; Basler, C.F.; Taubenberger, J.K.; Palese, P. A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J. Virol., 2005, 79(17), 11533-11536. (Pubitemid 41170697)
65. Srinivasan, A.; Viswanathan, K.; Raman, R.; Chandrasekaran, A.; Raguram, S.; Tumpey, T.M.; Sasisekharan, V.; Sasisekharan, R. Quantitative biochemical rationale for differences in transmissibility of 1918 pandemic influenza A viruses. Proc. Natl. Acad. Sci. U. S. A., 2008, 105(8), 2800-2805. (Pubitemid 351723624)
66. Tumpey, T.M.; Maines, T.R.; Van Hoeven, N.; Glaser, L.; Solorzano, A.; Pappas, C.; Cox, N.J.; Swayne, D.E.; Palese, P.; Katz, J.M.; Garcia-Sastre, A. A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science, 2007, 315(5812), 655-659. (Pubitemid 46214711)
67. Pappas, C.; Aguilar, P.V.; Basler, C.F.; Solorzano, A.; Zeng, H.; Perrone, L.A.; Palese, P.; Garcia-Sastre, A.; Katz, J.M.; Tumpey, T.M. Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus. Proc. Natl. Acad. Sci. U.S.A., 2008, 105(8), 3064-3069. (Pubitemid 351723668)
68. Van Hoeven, N.; Pappas, C.; Belser, J.A.; Maines, T.R.; Zeng, H.; Garcia- Sastre, A.; Sasisekharan, R.; Katz, J.M.; Tumpey, T.M. Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air. Proc. Natl. Acad. Sci. U. S. A., 2009, 106(9), 3366-3371.
69. Qi, L.; Kash, J.C.; Dugan, V.G.; Wang, R.; Jin, G.; Cunningham, R.E.; Taubenberger, J.K. Role of sialic acid binding specificity of the 1918 influenza virus hemagglutinin protein in virulence and pathogenesis for mice. J. Virol., 2009, 83(8), 3754-3761.
70. Ito, T.; Couceiro, J.; Kelm, S.; Baum, L.; Krauss, S.; Castrucci, M.; Donatelli, I.; Kida, H.; Paulson, J.; Webster, R. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J. Virol., 1998, 72(9), 7367.
71. Dawood, F.S.; Jain, S.; Finelli, L.; Shaw, M.W.; Lindstrom, S.; Garten, R.J.; Gubareva, L.V.; Xu, X.; Bridges, C.B.; Uyeki, T.M. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med., 2009, 360(25), 2605-2615.
72. Morens, D.M.; Taubenberger, J.K.; Fauci, A.S. The persistent legacy of the 1918 influenza virus. N. Engl. J. Med., 2009, 361(3), 225-229.
73. Garten, R.J.; Davis, C.T.; Russell, C.A.; Shu, B.; Lindstrom, S.; Balish, A.; Sessions, W.M.; Xu, X.; Skepner, E.; Deyde, V.; Okomo-Adhiambo, M.; Gubareva, L.; Barnes, J.; Smith, C.B.; Emery, S.L.; Hillman, M.J.; Rivailler, P.; Smagala, J.; de Graaf, M.; Burke, D.F.; Fouchier, R.A.; Pappas, C.; Alpuche-Aranda, C.M.; Lopez-Gatell, H.; Olivera, H.; Lopez, I.; Myers, C.A.; Faix, D.; Blair, P.J.; Yu, C.; Keene, K.M.; Dotson, P.D. Jr.; Boxrud, D.; Sambol, A.R.; Abid, S.H.; St George, K.; Bannerman, T.; Moore, A.L.; Stringer, D.J.; Blevins, P.; Demmler-Harrison, G.J.; Ginsberg, M.; Kriner, P.; Waterman, S.; Smole, S.; Guevara, H.F.; Belongia, E.A.; Clark, P.A.; Beatrice, S.T.; Donis, R.; Katz, J.; Finelli, L.; Bridges, C.B.; Shaw, M.; Jernigan, D.B.; Uyeki, T.M.; Smith, D.J.; Klimov, A.I.; Cox, N.J. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science, 2009, 325(5937), 197-201.
74. Soundararajan, V.; Tharakaraman, K.; Raman, R.; Raguram, S.; Shriver, Z.; Sasisekharan, V.; Sasisekharan, R. Extrapolating from sequence-the 2009 H1N1 'swine' influenza virus. Nat. Biotechnol., 2009, 27(6), 510-513.
75. Maines, T.R.; Jayaraman, A.; Belser, J.A.; Wadford, D.A.; Pappas, C.; Zeng, H.; Gustin, K.M.; Pearce, M.B.; Viswanathan, K.; Shriver, Z.H.; Raman, R.; Cox, N.J.; Sasisekharan, R.; Katz, J.M.; Tumpey, T.M. Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science, 2009, 325(5939), 484-487.
76. Childs, R.A.; Palma, A.S.; Wharton, S.; Matrosovich, T.; Liu, Y.; Chai, W.; Campanero-Rhodes, M.A.; Zhang, Y.; Eickmann, M.; Kiso, M.; Hay, A.; Matrosovich, M.; Feizi, T. Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nat. Biotechnol., 2009, 27(9), 797-799.
77. Liu, J.H.; Okazaki, K.; Bai, G.R.; Shi, W.M.; Mweene, A.; Kida, H. Interregional transmission of the internal protein genes of H2 influenza virus in migratory ducks from North America to Eurasia. Virus Genes., 2004, 29(1), 81-86. (Pubitemid 38903594)
78. Munster, V.J.; Baas, C.; Lexmond, P.; Waldenstrom, J.; Wallensten, A.; Fransson, T.; Rimmelzwaan, G.F.; Beyer, W.E.; Schutten, M.; Olsen, B.; Osterhaus, A.D.; Fouchier, R.A. Spatial, temporal, and species variation in prevalence of influenza A viruses in wild migratory birds. PLoS Pathog., 2007, 3(5), e61.
79. Liu, J.; Stevens, D.J.; Haire, L.F.; Walker, P.A.; Coombs, P.J.; Russell, R.J.; Gamblin, S.J.; Skehel, J.J. Structures of receptor complexes formed by hemagglutinins from the Asian Influenza pandemic of 1957. Proc. Natl. Acad. Sci. U. S. A., 2009, 106(40), 17175-17180.
80. Ma, W.; Vincent, A.L.; Gramer, M.R.; Brockwell, C.B.; Lager, K.M.; Janke, B.H.; Gauger, P.C.; Patnayak, D.P.; Webby, R.J.; Richt, J.A. Identification of H2N3 influenza A viruses from swine in the United States. Proc. Natl. Acad. Sci. U. S. A., 2007, 104(52), 20949-20954.
81. Matrosovich, M.; Matrosovich, T.; Uhlendorff, J.; Garten, W.; Klenk, H.D. Avian-virus-like receptor specificity of the hemagglutinin impedes influenza virus replication in cultures of human airway epithelium. Virology, 2007, 361(2), 384-390. (Pubitemid 46574852)
82. Smith, D.J.; Lapedes, A.S.; de Jong, J.C.; Bestebroer, T.M.; Rimmelzwaan, G.F.; Osterhaus, A.D.; Fouchier, R.A. Mapping the antigenic and genetic evolution of influenza virus. Science, 2004, 305(5682), 371-376. (Pubitemid 38938148)
83. Russell, C.A.; Jones, T.C.; Barr, I.G.; Cox, N.J.; Garten, R.J.; Gregory, V.; Gust, I.D.; Hampson, A.W.; Hay, A.J.; Hurt, A.C.; de Jong, J.C.; Kelso, A.; Klimov, A.I.; Kageyama, T.; Komadina, N.; Lapedes, A.S.; Lin, Y.P.; Mosterin, A.; Obuchi, M.; Odagiri, T.; Osterhaus, A.D.; Rimmelzwaan, G.F.; Shaw, M.W.; Skepner, E.; Stohr, K.; Tashiro, M.; Fouchier, R.A.; Smith, D.J. The global circulation of seasonal influenza A (H3N2) viruses. Science, 2008, 320(5874), 340-346. (Pubitemid 351555652)
84. Nobusawa, E.; Ishihara, H.; Morishita, T.; Sato, K.; Nakajima, K. Change in receptor-binding specificity of recent human influenza A viruses (H3N2): A single amino acid change in hemagglutinin altered its recognition of sialyloligosaccharides. Virology, 2000, 278(2), 587-596. (Pubitemid 32012792)
85. Medeiros, R.; Escriou, N.; Naffakh, N.; Manuguerra, J.C.; van der Werf, S. Hemagglutinin residues of recent human A(H3N2) influenza viruses that contribute to the inability to agglutinate chicken erythrocytes. Virology, 2001, 289(1), 74-85. (Pubitemid 33016239)
86. Owen, R.E.; Yamada, E.; Thompson, C.I.; Phillipson, L.J.; Thompson, C.; Taylor, E.; Zambon, M.; Osborn, H.M.; Barclay, W.S.; Borrow, P. Alterations in receptor binding properties of recent human influenza H3N2 viruses are associated with reduced natural killer cell lysis of infected cells. J. Virol., 2007, 81(20), 11170-11178. (Pubitemid 47536089)
87. Abe, Y.; Takashita, E.; Sugawara, K.; Matsuzaki, Y.; Muraki, Y.; Hongo, S. Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin. J. Virol., 2004, 78(18), 9605-9611. (Pubitemid 39187078)
88. Kumari, K.; Gulati, S.; Smith, D.F.; Gulati, U.; Cummings, R.D.; Air, G.M. Receptor binding specificity of recent human H3N2 influenza viruses. Virol. J., 2007, 4, 42.
89. Pekosz, A.; Newby, C.; Bose, P.S.; Lutz, A. Sialic acid recognition is a key determinant of influenza A virus tropism in murine trachea epithelial cell cultures. Virology, 2009, 386(1), 61-67.
90. Auewarakul, P.; Suptawiwat, O.; Kongchanagul, A.; Sangma, C.; Suzuki, Y.; Ungchusak, K.; Louisirirotchanakul, S.; Lerdsamran, H.; Pooruk, P.; Thitithanyanont, A.; Pittayawonganon, C.; Guo, C.T.; Hiramatsu, H.; Jampangern, W.; Chunsutthiwat, S.; Puthavathana, P. An avian influenza H5N1 virus that binds to a human-type receptor. J. Virol., 2007, 81(18), 9950-9955. (Pubitemid 350067698)
91. Stevens, J.; Blixt, O.; Chen, L.M.; Donis, R.O.; Paulson, J.C.; Wilson, I.A. Recent avian H5N1 viruses exhibit increased propensity for acquiring human receptor specificity. J. Mol. Biol., 2008, 381(5), 1382-1394.
92. Kongchanagul, A.; Suptawiwat, O.; Kanrai, P.; Uiprasertkul, M.; Puthavathana, P.; Auewarakul, P. Positive selection at the receptor-binding site of haemagglutinin H5 in viral sequences derived from human tissues. J. Gen. Virol., 2008, 89(Pt 8), 1805-1810.
93. Chandrasekaran, A.; Srinivasan, A.; Raman, R.; Viswanathan, K.; Raguram, S.; Tumpey, T.M.; Sasisekharan, V.; Sasisekharan, R. Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat. Biotechnol., 2008, 26(1), 107-113.
94. Belser, J.A.; Blixt, O.; Chen, L.M.; Pappas, C.; Maines, T.R.; Van Hoeven, N.; Donis, R.; Busch, J.; McBride, R.; Paulson, J.C.; Katz, J.M.; Tumpey, T.M. Contemporary North American influenza H7 viruses possess human receptor specificity: Implications for virus transmissibility. Proc. Natl. Acad. Sci. U. S. A., 2008, 105(21), 7558-7563. (Pubitemid 351830057)
95. Sorrell, E.M.; Wan, H.; Araya, Y.; Song, H.; Perez, D.R. Minimal molecular constraints for respiratory droplet transmission of an avian-human H9N2 influenza A virus. Proc. Natl. Acad. Sci. U. S. A., 2009, 106(18), 7565-7570.
96. Karlsson Hedestam, G.B.; Fouchier, R.A.; Phogat, S.; Burton, D.R.; Sodroski, J.; Wyatt, R.T. The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus. Nat. Rev. Microbiol., 2008, 6(2), 143-155.
97. Davies, J. Swine flu vaccines: Reaching the finish line. Cell, 2009, 139(3), 449-451.
98. Caton, A.J.; Brownlee, G.G.; Yewdell, J.W.; Gerhard, W. The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell, 1982, 31(2 Pt 1), 417-427. (Pubitemid 13178866)
99. Tsuchiya, E.; Sugawara, K.; Hongo, S.; Matsuzaki, Y.; Muraki, Y.; Li, Z.N.; Nakamura, K. Antigenic structure of the haemagglutinin of human influenza A/H2N2 virus. J. Gen. Virol., 2001, 82(Pt 10), 2475-2484. (Pubitemid 32936780)
100. Wiley, D.C.; Wilson, I.A.; Skehel, J.J. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature, 1981, 289(5796), 373-378. (Pubitemid 11135143)
101. Kaverin, N.V.; Rudneva, I.A.; Ilyushina, N.A.; Varich, N.L.; Lipatov, A.S.; Smirnov, Y.A.; Govorkova, E.A.; Gitelman, A.K.; Lvov, D.K.; Webster, R.G. Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants. J. Gen. Virol., 2002, 83(Pt 10), 2497-2505.
102. Knossow, M.; Gaudier, M.; Douglas, A.; Barrere, B.; Bizebard, T.; Barbey, C.; Gigant, B.; Skehel, J.J. Mechanism of neutralization of influenza virus infectivity by antibodies. Virology, 2002, 302(2), 294-298. (Pubitemid 35373857)
103. Ndifon, W.; Wingreen, N.S.; Levin, S.A. Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccines. Proc. Natl. Acad. Sci. U. S. A., 2009, 106(21), 8701-8706.
104. Gocnik, M.; Fislova, T.; Sladkova, T.; Mucha, V.; Kostolansky, F.; Vareckova, E. Antibodies specific to the HA2 glycopolypeptide of influenza A virus haemagglutinin with fusion-inhibition activity contribute to the protection of mice against lethal infection. J. Gen. Virol., 2007, 88(Pt 3), 951-955. (Pubitemid 46359566)
105. Ekiert, D.C.; Bhabha, G.; Elsliger, M.A.; Friesen, R.H.; Jongeneelen, M.; Throsby, M.; Goudsmit, J.; Wilson, I.A. Antibody recognition of a highly conserved influenza virus epitope. Science, 2009, 324(5924), 246-251.
106. Sui, J.; Hwang, W.C.; Perez, S.; Wei, G.; Aird, D.; Chen, L.M.; Santelli, E.; Stec, B.; Cadwell, G.; Ali, M.; Wan, H.; Murakami, A.; Yammanuru, A.; Han, T.; Cox, N.J.; Bankston, L.A.; Donis, R.O.; Liddington, R.C.; Marasco, W.A. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol., 2009, 16(3), 265-273.
107. Wang, C.C.; Chen, J.R.; Tseng, Y.C.; Hsu, C.H.; Hung, Y.F.; Chen, S.W.; Chen, C.M.; Khoo, K.H.; Cheng, T.J.; Cheng, Y.S.; Jan, J.T.; Wu, C.Y.; Ma, C.; Wong, C.H. Glycans on influenza hemagglutinin affect receptor binding and immune response. Proc. Natl. Acad. Sci. U. S. A., 2009, 106(43), 18137-18142.
108. Hensley, S.E.; Das, S.R.; Bailey, A.L.; Schmidt, L.M.; Hickman, H.D.; Jayaraman, A.; Viswanathan, K.; Raman, R.; Sasisekharan, R.; Bennink, J.R.; Yewdell, J.W. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science, 2009, 326(5953), 734-736.
109. Wagner, R.; Matrosovich, M.; Klenk, H.D. Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev. Med. Virol., 2002, 12(3), 159-166. (Pubitemid 34516947)
110. Davenport, F.M.; Hennessy, A.V.; Francis, T. Jr. Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus. J. Exp. Med., 1953, 98(6), 641-656.
111. Francis Jr, T. On the doctrine of original antigenic sin. Proceedings. of. the. American. Philosophical. Society., 1960, 104(6), 572-578.
112. Francis Jr, T. Influenza: The new acquaintance. Ann. Intern. Med., 1953, 39, 203-221.
113. Klenerman, P.; Zinkernagel, R.M. Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes. Nature, 1998, 394(6692), 482-485. (Pubitemid 28373959)
114. Kim, J.H.; Skountzou, I.; Compans, R.; Jacob, J. Original antigenic sin responses to influenza viruses. J. Immunol., 2009, 183(5), 3294-3301.
115. Throsby, M.; van den Brink, E.; Jongeneelen, M.; Poon, L.L.; Alard, P.; Cornelissen, L.; Bakker, A.; Cox, F.; van Deventer, E.; Guan, Y.; Cinatl, J.; ter Meulen, J.; Lasters, I.; Carsetti, R.; Peiris, M.; de Kruif, J.; Goudsmit, J. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS One, 2008, 3(12), e3942.
116. Matrosovich, M.; Klenk, H.D. Natural and synthetic sialic acid-containing inhibitors of influenza virus receptor binding. Rev. Med. Virol., 2003, 13(2), 85-97. (Pubitemid 36323672)
117. Sun, X.L. Recent anti-influenza strategies in multivalent sialyloligosaccharides and sialylmimetics approaches. Curr. Med. Chem., 2007, 14(21), 2304-2313.
118. Ogata, M.; Murata, T.; Murakami, K.; Suzuki, T.; Hidari, K.I.; Suzuki, Y.; Usui, T. Chemoenzymatic synthesis of artificial glycopolypeptides containing multivalent sialyloligosaccharides with a gamma-polyglutamic acid backbone and their effect on inhibition of infection by influenza viruses. Bioorg. Med. Chem., 2007, 15(3), 1383-1393. (Pubitemid 46038129)
119. Umemura, M.; Itoh, M.; Makimura, Y.; Yamazaki, K.; Umekawa, M.; Masui, A.; Matahira, Y.; Shibata, M.; Ashida, H.; Yamamoto, K. Design of a sialylglycopolymer with a chitosan backbone having efficient inhibitory activity against influenza virus infection. J. Med. Chem., 2008, 51(15), 4496-4503.
120. Hidari, K.I.; Murata, T.; Yoshida, K.; Takahashi, Y.; Minamijima, Y.H.; Miwa, Y.; Adachi, S.; Ogata, M.; Usui, T.; Suzuki, Y.; Suzuki, T. Chemoenzymatic synthesis, characterization, and application of glycopolymers carrying lactosamine repeats as entry inhibitors against influenza virus infection. Glycobiology, 2008, 18(10), 779-788.
121. Ogata, M.; Hidari, K.I.; Kozaki, W.; Murata, T.; Hiratake, J.; Park, E.Y.; Suzuki, T.; Usui, T. Molecular Design of Spacer-N-Linked Sialoglycopolypeptide as Polymeric Inhibitors Against Influenza Virus Infection. Biomacromolecules, 2009.
122. Song, J.M.; Park, K.D.; Lee, K.H.; Byun, Y.H.; Park, J.H.; Kim, S.H.; Kim, J.H.; Seong, B.L. Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives. Antiviral Res., 2007, 76(2), 178-185. (Pubitemid 47422312)
123. Gabrielian, E.S.; Shukarian, A.K.; Goukasova, G.I.; Chandanian, G.L.; Panossian, A.G.; Wikman, G.; Wagner, H. A double blind, placebocontrolled study of Andrographis paniculata fixed combination Kan Jang in the treatment of acute upper respiratory tract infections including sinusitis. Phytomedicine, 2002, 9(7), 589-597. (Pubitemid 35397789)
124. Chen, J.X.; Xue, H.J.; Ye, W.C.; Fang, B.H.; Liu, Y.H.; Yuan, S.H.; Yu, P.; Wang, Y.Q. Activity of andrographolide and its derivatives against influenza virus in vivo and in vitro. Biol. Pharm. Bull., 2009, 32(8), 1385-1391.
125. Song, G.; Yang, S.; Zhang, W.; Cao, Y.; Wang, P.; Ding, N.; Zhang, Z.; Guo, Y.; Li, Y. Discovery of the First Series of Small Molecule H5N1 Entry Inhibitors. J. Med. Chem., 2009.
126. Chen, D.Y.; Shien, J.H.; Tiley, L.; Chiou, S.S.; Wang, S.Y.; Chang, T.J.; Lee, Y.J.; Chan, K.W.; Hsu, W.L. Curcumin inhibits influenza virus infection and haemagglutination activity. Food Chem., 2010, 119(4), 1346-1351.
127. Jones, J.C.; Turpin, E.A.; Bultmann, H.; Brandt, C.R.; Schultz-Cherry, S. Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells. J. Virol., 2006, 80(24), 11960-11967. (Pubitemid 44904345)
128. Rajik, M.; Omar, A.R.; Ideris, A.; Hassan, S.S.; Yusoff, K. A novel peptide inhibits the influenza virus replication by preventing the viral attachment to the host cells. Int. J. Biol. Sci., 2009, 5(6), 543-548.
129. Matsubara, T.; Sumi, M.; Kubota, H.; Taki, T.; Okahata, Y.; Sato, T. Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library. J. Med. Chem., 2009, 52(14), 4247-4256.
130. Ladner, R.C.; Sato, A.K.; Gorzelany, J.; de Souza, M. Phage display-derived peptides as therapeutic alternatives to antibodies. Drug Discov. Today, 2004, 9(12), 525-529. (Pubitemid 38739333)
131. Malakhov, M.P.; Aschenbrenner, L.M.; Smee, D.F.; Wandersee, M.K.; Sidwell, R.W.; Gubareva, L.V.; Mishin, V.P.; Hayden, F.G.; Kim, D.H.; Ing, A.; Campbell, E.R.; Yu, M.; Fang, F. Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection. Antimicrob. Agents Chemother., 2006, 50(4), 1470-1479.
132. Matsumoto, K.; Ogawa, N.; Nerome, K.; Numazaki, Y.; Kawakami, Y.; Shirato, K.; Arakawa, M.; Kudoh, S.; Shimokata, K.; Nakajima, S.; Yamakido, M.; Kashiwagi, S.; Nagatake, T. Safety and efficacy of the neuraminidase inhibitor zanamivir in treating influenza virus infection in adults: Results from Japan. GG167 Group. Antivir. Ther., 1999, 4(2), 61-68. (Pubitemid 29355843)
133. Triana-Baltzer, G.B.; Gubareva, L.V.; Klimov, A.I.; Wurtman, D.F.; Moss, R.B.; Hedlund, M.; Larson, J.L.; Belshe, R.B.; Fang, F. Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein. PLoS One, 2009, 4(11), e7838.
134. Boriskin, Y.S.; Leneva, I.A.; Pecheur, E.I.; Polyak, S.J. Arbidol: A broadspectrum antiviral compound that blocks viral fusion. Curr. Med. Chem., 2008, 15(10), 997-1005. (Pubitemid 351736402)
135. Leneva, I.A.; Russell, R.J.; Boriskin, Y.S.; Hay, A.J. Characteristics of arbidol-resistant mutants of influenza virus: Implications for the mechanism of anti-influenza action of arbidol. Antiviral. Res., 2009, 81(2), 132-140.
136. Hsieh, H.P.; Hsu, J.T. Strategies of development of antiviral agents directed against influenza virus replication. Curr. Pharm. Des., 2007, 13(34), 3531-3542. (Pubitemid 350238942)
137. Hoffman, L.R.; Kuntz, I.D.; White, J.M. Structure-based identification of an inducer of the low-pH conformational change in the influenza virus hemagglutinin: Irreversible inhibition of infectivity. J. Virol., 1997, 71(11), 8808-8820. (Pubitemid 27446465)
138. Russell, R.J.; Kerry, P.S.; Stevens, D.J.; Steinhauer, D.A.; Martin, S.R.; Gamblin, S.J.; Skehel, J.J. Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion. Proc. Natl. Acad. Sci. U. S. A., 2008, 105(46), 17736-17741.
139. Murti, K.G.; Webster, R.G. Distribution of hemagglutinin and neuraminidase on influenza virions as revealed by immunoelectron microscopy. Virology, 1986, 149(1), 36-43. (Pubitemid 16174976)
140. Liu, C.; Eichelberger, M.C.; Compans, R.W.; Air, G.M. Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding. J. Virol., 1995, 69(2), 1099-1106.
141. Gong, J.; Xu, W.; Zhang, J. Structure and functions of influenza virus neuraminidase. Curr. Med. Chem., 2007, 14(1), 113-122. (Pubitemid 46050308)
142. Varghese, J.N.; Colman, P.M. Three-dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 at 2.2 A resolution. J. Mol. Biol., 1991, 221(2), 473-486. (Pubitemid 121003395)
143. von Itzstein, M. The war against influenza: Discovery and development of sialidase inhibitors. Nat. Rev. Drug Discov., 2007, 6(12), 967-974.
144. Liu, Y.; Zhang, J.; Xu, W. Recent progress in rational drug design of neuraminidase inhibitors. Curr. Med. Chem., 2007, 14(27), 2872-2891. (Pubitemid 350201654)
145. Mishin, V.P.; Hayden, F.G.; Gubareva, L.V. Susceptibilities of antiviralresistant influenza viruses to novel neuraminidase inhibitors. Antimicrob. Agents Chemother., 2005, 49(11), 4515-4520. (Pubitemid 41552580)
146. Yun, N.E.; Linde, N.S.; Zacks, M.A.; Barr, I.G.; Hurt, A.C.; Smith, J.N.; Dziuba, N.; Holbrook, M.R.; Zhang, L.; Kilpatrick, J.M.; Arnold, C.S.; Paessler, S. Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1). Virology, 2008, 374(1), 198-209.
147. Baz, M.; Abed, Y.; Nehme, B.; Boivin, G. Activity of the oral neuraminidase inhibitor A-322278 against the oseltamivir-resistant H274Y (A/H1N1) influenza virus mutant in mice. Antimicrob. Agents Chemother., 2009, 53(2), 791-793.
148. Birnkrant, D.; Cox, E. The emergency use authorization of peramivir for treatment of 2009 H1N1 influenza. N. Engl. J. Med., 2009, 361(23), 2204.
149. Russell, R.J.; Haire, L.F.; Stevens, D.J.; Collins, P.J.; Lin, Y.P.; Blackburn, G.M.; Hay, A.J.; Gamblin, S.J.; Skehel, J.J. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature, 2006, 443(7107), 45-49. (Pubitemid 44344043)
150. Amaro, R.E.; Minh, D.D.; Cheng, L.S.; Lindstrom, W.M. Jr.; Olson, A.J.; Lin, J.H.; Li, W.W.; McCammon, J.A. Remarkable loop flexibility in avian influenza N1 and its implications for antiviral drug design. J. Am. Chem. Soc., 2007, 129(25), 7764-7765. (Pubitemid 46998169)
151. Malaisree, M.; Rungrotmongkol, T.; Decha, P.; Intharathep, P.; Aruksakunwong, O.; Hannongbua, S. Understanding of known drug-target interactions in the catalytic pocket of neuraminidase subtype N1. Proteins, 2008, 71(4), 1908-1918. (Pubitemid 351732944)
152. Landon, M.R.; Amaro, R.E.; Baron, R.; Ngan, C.H.; Ozonoff, D.; McCammon, J.A.; Vajda, S. Novel druggable hot spots in avian influenza neuraminidase H5N1 revealed by computational solvent mapping of a reduced and representative receptor ensemble. Chem. Biol. Drug Des., 2008, 71(2), 106-116. (Pubitemid 351160979)
153. Amaro, R.E.; Cheng, X.; Ivanov, I.; Xu, D.; McCammon, J.A. Characterizing loop dynamics and ligand recognition in human- and avian-type influenza neuraminidases via generalized born molecular dynamics and end-point free energy calculations. J. Am. Chem. Soc., 2009, 131(13), 4702-4709.
154. Calligari, P.A.; Kneller, G.R.; Giansanti, A.; Ascenzi, P.; Porrello, A.; Bocedi, A. Inhibition of viral group-1 and group-2 neuraminidases by oseltamivir: A comparative structural analysis by the ScrewFit algorithm. Biophys. Chem., 2009, 141(1), 117-123.
155. Ferraris, O.; Lina, B. Mutations of neuraminidase implicated in neuraminidase inhibitors resistance. J. Clin. Virol., 2008, 41(1), 13-19. (Pubitemid 350298978)
156. Du, Q.S.; Wang, S.Q.; Chou, K.C. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drugresistant H5N1 virus. Biochem. Biophys. Res. Commun., 2007, 362(2), 525-531.
157. Mitrasinovic, P.M. On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA). Biophys. Chem., 2009, 140(1- 3), 35-38.
158. Rungrotmongkol, T.; Frecer, V.; De-Eknamkul, W.; Hannongbua, S.; Miertus, S. Design of oseltamivir analogs inhibiting neuraminidase of avian influenza virus H5N1. Antiviral. Res., 2009, 82(1), 51-58.
159. D'Ursi, P.; Chiappori, F.; Merelli, I.; Cozzi, P.; Rovida, E.; Milanesi, L. Virtual screening pipeline and ligand modelling for H5N1 neuraminidase. Biochem. Biophys. Res. Commun., 2009, 383(4), 445-449.
160. Li, Y.; Zhou, B.; Wang, R. Rational design of Tamiflu derivatives targeting at the open conformation of neuraminidase subtype 1. J. Mol. Graph. Model., 2009, 28(3), 203-219.
161. Cheng, L.S.; Amaro, R.E.; Xu, D.; Li, W.W.; Arzberger, P.W.; McCammon, J.A. Ensemble-based virtual screening reveals potential novel antiviral compounds for avian influenza neuraminidase. J. Med. Chem., 2008, 51(13), 3878-3894. (Pubitemid 351956517)
162. Garcia-Sosa, A.T.; Sild, S.; Maran, U. Design of multi-binding-site inhibitors, ligand efficiency, and consensus screening of avian influenza H5N1 wild-type neuraminidase and of the oseltamivir-resistant H274Y variant. J. Chem. Inf. Model., 2008, 48(10), 2074-2080.
163. Nagai, T.; Miyaichi, Y.; Tomimori, T.; Suzuki, Y.; Yamada, H. Inhibition of influenza virus sialidase and anti-influenza virus activity by plant flavonoids. Chem. Pharm. Bull. (Tokyo), 1990, 38(5), 1329-1332. (Pubitemid 20290829)
164. Wei, F.; Ma, S.C.; Ma, L.Y.; But, P.P.; Lin, R.C.; Khan, I.A. Antiviral flavonoids from the seeds of Aesculus chinensis. J. Nat. Prod., 2004, 67(4), 650-653. (Pubitemid 38533938)
165. Miki, K.; Nagai, T.; Suzuki, K.; Tsujimura, R.; Koyama, K.; Kinoshita, K.; Furuhata, K.; Yamada, H.; Takahashi, K. Anti-influenza virus activity of biflavonoids. Bioorg. Med. Chem. Lett., 2007, 17(3), 772-775. (Pubitemid 46108558)
166. Nagai, T.; Moriguchi, R.; Suzuki, Y.; Tomimori, T.; Yamada, H. Mode of action of the anti-influenza virus activity of plant flavonoid, 5,7,4'- trihydroxy-8-methoxyflavone, from the roots of Scutellaria baicalensis. Antiviral. Res., 1995, 26(1), 11-25.
167. Liu, A.L.; Wang, H.D.; Lee, S.M.; Wang, Y.T.; Du, G.H. Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities. Bioorg. Med. Chem., 2008, 16(15), 7141-7147.
168. Mercader, A.G.; Pomilio, A.B. QSAR study of flavonoids and biflavonoids as influenza H1N1 virus neuraminidase inhibitors. Eur. J. Med. Chem., 2010, 45(5), 1724-1730.
169. Ryu, Y.B.; Curtis-Long, M.J.; Lee, J.W.; Ryu, H.W.; Kim, J.Y.; Lee, W.S.; Park, K.H. Structural characteristics of flavanones and flavones from Cudrania tricuspidata for neuraminidase inhibition. Bioorg. Med. Chem. Lett., 2009, 19(17), 4912-4915.
170. Jeong, H.J.; Ryu, Y.B.; Park, S.J.; Kim, J.H.; Kwon, H.J.; Park, K.H.; Rho, M.C.; Lee, W.S. Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities. Bioorg. Med. Chem., 2009, 17(19), 6816-6823.
171. Ryu, Y.B.; Curtis-Long, M.J.; Kim, J.H.; Jeong, S.H.; Yang, M.S.; Lee, K.W.; Lee, W.S.; Park, K.H. Pterocarpans and flavanones from Sophora flavescens displaying potent neuraminidase inhibition. Bioorg. Med. Chem. Lett., 2008, 18(23), 6046-6049.
172. Ryu, Y.B.; Curtis-Long, M.J.; Lee, J.W.; Kim, J.H.; Kim, J.Y.; Kang, K.Y.; Lee, W.S.; Park, K.H. Characteristic of neuraminidase inhibitory xanthones from Cudrania tricuspidata. Bioorg. Med. Chem., 2009, 17(7), 2744-2750.
173. Ryu, Y.B.; Kim, J.H.; Park, S.J.; Chang, J.S.; Rho, M.C.; Bae, K.H.; Park, K.H.; Lee, W.S. Inhibition of neuraminidase activity by polyphenol compounds isolated from the roots of Glycyrrhiza uralensis. Bioorg. Med. Chem. Lett., 2010, 20(3), 971-974.
174. Grienke, U.; Schmidtke, M.; Kirchmair, J.; Pfarr, K.; Wutzler, P.; Durrwald, R.; Wolber, G.; Liedl, K.R.; Stuppner, H.; Rollinger, J.M. Antiviral Potential and Molecular Insight into Neuraminidase Inhibiting Diarylheptanoids from Alpinia katsumadai. J. Med. Chem., 2010, 53(2), 778-786.
175. Steward, D.L.; Martin, J.; Grollman, A.P. Inhibition of influenza virus by triphenylmethane compounds. Ann. N. Y. Acad. Sci., 1977, 284, 638-649. (Pubitemid 8067797)
176. Liao, L.L.; Horwitz, S.B.; Huang, M.T.; Grollman, A.P.; Steward, D.; Martin, J. Triphenylmethane dyes as inhibitors of reverse transcriptase, ribonucleic acid polymerase, and protein synthesis. Structure-activity relationships. J. Med. Chem., 1975, 18(1), 117-120.
177. Hung, H.C.; Tseng, C.P.; Yang, J.M.; Ju, Y.W.; Tseng, S.N.; Chen, Y.F.; Chao, Y.S.; Hsieh, H.P.; Shih, S.R.; Hsu, J.T. Aurintricarboxylic acid inhibits influenza virus neuraminidase. Antiviral. Res., 2009, 81(2), 123-131.
178. Hashem, A.M.; Flaman, A.S.; Farnsworth, A.; Brown, E.G.; Van Domselaar, G.; He, R.T.; Li, X.G. Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A and B Virus Neuraminidases. PLoS One, 2009, 4(12), -.
179. Sun, C.; Zhang, X.; Huang, H.; Zhou, P. Synthesis and evaluation of a new series of substituted acyl(thio)urea and thiadiazolo [2,3-a] pyrimidine derivatives as potent inhibitors of influenza virus neuraminidase. Bioorg. Med. Chem., 2006, 14(24), 8574-8581. (Pubitemid 44667533)
180. Nair, P.C.; Sobhia, M.E. Quantitative structure activity relationship studies on thiourea analogues as influenza virus neuraminidase inhibitors. Eur. J. Med. Chem., 2008, 43(2), 293-299. (Pubitemid 351215598)
181. Platis, D.; Smith, B.J.; Huyton, T.; Labrou, N.E. Structure-guided design of a novel class of benzyl-sulfonate inhibitors for influenza virus neuraminidase. Biochem. J., 2006, 399(2), 215-223. (Pubitemid 44570283)
182. An, J.; Lee, D.C.; Law, A.H.; Yang, C.L.; Poon, L.L.; Lau, A.S.; Jones, S.J. A novel small-molecule inhibitor of the avian influenza H5N1 virus determined through computational screening against the neuraminidase. J. Med. Chem., 2009, 52(9), 2667-2672.
183. Macdonald, S.J.; Watson, K.G.; Cameron, R.; Chalmers, D.K.; Demaine, D.A.; Fenton, R.J.; Gower, D.; Hamblin, J.N.; Hamilton, S.; Hart, G.J.; Inglis, G.G.; Jin, B.; Jones, H.T.; McConnell, D.B.; Mason, A.M.; Nguyen, V.; Owens, I.J.; Parry, N.; Reece, P.A.; Shanahan, S.E.; Smith, D.; Wu, W.Y.; Tucker, S.P. Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimen. Antimicrob. Agents Chemother., 2004, 48(12), 4542-4549. (Pubitemid 39577651)
184. Macdonald, S.J.; Cameron, R.; Demaine, D.A.; Fenton, R.J.; Foster, G.; Gower, D.; Hamblin, J.N.; Hamilton, S.; Hart, G.J.; Hill, A.P.; Inglis, G.G.; Jin, B.; Jones, H.T.; McConnell, D.B.; McKimm-Breschkin, J.; Mills, G.; Nguyen, V.; Owens, I.J.; Parry, N.; Shanahan, S.E.; Smith, D.; Watson, K.G.; Wu, W.Y.; Tucker, S.P. Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenza. J. Med. Chem., 2005, 48(8), 2964-2971. (Pubitemid 40548109)
185. Yamashita, M.; Tomozawa, T.; Kakuta, M.; Tokumitsu, A.; Nasu, H.; Kubo, S. CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity. Antimicrob. Agents Chemother., 2009, 53(1), 186-192.